Susan Fox, PhD, ChB, MB BCh

Translational studies of new treatments for movement disorders, including phase II and phase IIII clinical studies.
Mov Disord Clin Pract. 2018 Jan-Feb;5(1):66-74
Udow SJ, Hobson DE, Kleiner G, Masellis M, Fox SH, Lang AE, Marras C
Ann Neurol. 2018 Oct 24;:
Espay AJ, Morgante F, Merola A, Fasano A, Marsili L, Fox SH, Bezard E, Picconi B, Calabresi P, Lang AE
Neuropharmacology. 2018 Jun 01;:
Johnston TH, Lacoste AMB, Visanji NP, Lang AE, Fox SH, Brotchie JM
Parkinsonism Relat Disord. 2018 May 05;:
Li MH, Mestre TA, Fox SH, Taati B
Curr Opin Neurol. 2018 May 08;:
Kulisevsky J, Oliveira L, Fox SH
Front Aging Neurosci. 2018;10:120
Martinez M, Multani N, Anor CJ, Misquitta K, Tang-Wai DF, Keren R, Fox S, Lang AE, Marras C, Tartaglia MC
Mov Disord. 2018 Mar 23;:
Fox SH, Katzenschlager R, Lim SY, Barton B, de Bie RMA, Seppi K, Coelho M, Sampaio C, Movement Disorder Society Evidence-Based Medicine Committee

Pages